• Users Online: 1181
  • Home
  • Print this page
  • Email this page
Year : 2000  |  Volume : 48  |  Issue : 4  |  Page : 263-78

New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.

R.P Centre for Ophthalmic Sciences, AIIMS, New Delhi, India

Correspondence Address:
L Verma
R.P Centre for Ophthalmic Sciences, AIIMS, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 11340884

Rights and PermissionsRights and Permissions

Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly population. The prevalence is reported to be 1.2-1.4% in several population-based epidemiological studies. Currently 25-30 million people worldwide are blind due to AMD. With the aging world population it is bound to increase significantly, and could become a significant public health problem in next two decades, with serious socio-economic implications. Several strategies are today available to treat the wet form of AMD, which is responsible for significant visual loss. These were until recently confined to laser photocoagulation, and subretinal surgery, but today two other modalities, namely, radiation and photodynamic therapy, are available. These treatment modalities however, are aimed at preservation of vision only, and not at reversing the process of the disease. Further research on antiangiogenic drugs and gene therapy could significantly help AMD patients.

[FULL TEXT] [PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded5    
    Comments [Add]    
    Cited by others 10    

Recommend this journal